Moreover, almost most of the analyzed parameters were higher in patients with CLL EBV+, with the exception of CD8+ PD-1+ and CD8+ CTLA-4+, which were 1.16 times and 1.32 times higher, respectively, in patients with CVID EBV+. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.